Table 2.
Agent | Total (n = 108) |
E. anophelis (n = 90) |
E. meningoseptica (n = 7) |
E. miricola cluster (n = 11)c |
||||
---|---|---|---|---|---|---|---|---|
MD | VMD | MD | VMD | MD | VMD | MD | VMD | |
Amikacin | 12.1 | 0 | 5.6 | 0 | 0 | 0 | 72.7 | 0 |
Ampicillin/sulbactam | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cefepime | 0.9 | 0 | 1.1 | 0 | 0 | 0 | 0 | 0 |
Cefotaxime | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ceftazidime | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ciprofloxacin | 0 | 8.3 | 0 | 8.9 | 0 | 0 | 0 | 9.1 |
Colistin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gentamicin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Imipenem | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Levofloxacin | 0 | 0.9 | 0 | 1.1 | 0 | 0 | 0 | 0 |
Meropenem | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minocycline | 0.9 | 0 | 0 | 0 | 0 | 0 | 9.1 | 0 |
Moxifloxacin | 0.9 | 5.6 | 0 | 6.7 | 0 | 0 | 9.1 | 0 |
Piperacillin/tazobactam | 6.5 | 0 | 3.3 | 0 | 14.3 | 0 | 27.3 | 0 |
Rifampin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tigecycline | 11.1 | 0 | 7.8 | 0 | 42.9 | 0 | 18.2 | 0 |
Trimethoprim/sulfamethoxazole | 45.4 | 0 | 50 | 0 | 57.1 | 0 | 0 | 0 |
Vancomycin | 0 | 3.7 | 0 | 1.1 | 0 | 14.3 | 0 | 18.2 |
Data are presented as percentages (%).
MD rates of >3.0% or VMD rates of >1.5% are underlined.
E. miricola cluster comprised E. miricola (6), E. bruuniana (3) and E. ursingii (2); no E. occulta isolates were identified.